Scholar Rock Holding (SRRK) Equity Average (2018 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Equity Average of $260.8 million in Q1 2026, up 6.32% quarter-over-quarter from $245.2 million in Q4 2025, and down 23.42% on a YoY basis from $340.5 million in Q1 2025.

Scholar Rock Holding (SRRK) Equity Average (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Equity Average history runs 9 years deep, the most recent figure standing at $260.8 million for Q1 2026.

  • In Q1 2026, Equity Average fell 23.42% year-over-year to $260.8 million; the TTM figure through Mar 2026 stood at $260.8 million (down 23.42% YoY), while the FY2025 annual figure was $307.1 million, up 3.41% from the prior year.
  • Equity Average was $260.8 million for Q1 2026 at Scholar Rock Holding, up from $245.2 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $340.5 million in Q1 2025 to a low of $106.4 million in Q3 2024.
  • Historically, Equity Average has averaged $229.6 million across 5 years, with a median of $239.1 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Equity Average tumbled 42.51% in 2024, then surged 124.74% in 2025.
  • A 5-year view of Equity Average shows it stood at $276.8 million in 2022, then slipped by 29.02% to $196.4 million in 2023, then advanced by 13.99% to $223.9 million in 2024, then increased by 9.52% to $245.2 million in 2025, then gained by 6.32% to $260.8 million in 2026.
  • The last three Equity Average figures came in at $260.8 million (Q1 2026), $245.2 million (Q4 2025), and $239.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 3.50 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 783.14 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.76 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.01 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 21.35 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.01 Bn
9 Abivax 91.96 Bn 91.96 Bn - 516.41 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 260.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 260.75 Mn
Dec 31, 2025 245.24 Mn
Sep 30, 2025 239.14 Mn
Jun 30, 2025 272.81 Mn
Mar 31, 2025 340.48 Mn
Dec 31, 2024 223.92 Mn
Sep 30, 2024 106.41 Mn
Jun 30, 2024 158.20 Mn
Mar 31, 2024 204.00 Mn
Dec 31, 2023 196.44 Mn
Sep 30, 2023 185.08 Mn
Jun 30, 2023 215.58 Mn
Mar 31, 2023 244.44 Mn
Dec 31, 2022 276.75 Mn
Sep 30, 2022 311.39 Mn
Jun 30, 2022 250.41 Mn
Mar 31, 2022 171.70 Mn
Dec 31, 2021 179.67 Mn
Sep 30, 2021 201.96 Mn
Jun 30, 2021 228.60 Mn